|
Verzögert
Toronto S.E.
14:50:29 26.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 9.210 CAD | +0.88% |
|
+0.33% | +16.29% |
| 05.10. | Satellos Bioscience erhält vom USPTO ein Stoffpatent für Forazapadin | MT |
| 05.10. | Satellos Bioscience erhält US-Patent für Forazapadin | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.88% | +0.33% | -26.05% | -30.75% | +16.29% | +11.23% | +113.19% | -48.14% | - | 138 Mio. | ||
| +2.41% | +0.29% | -10.89% | +15.78% | +59.66% | +39.41% | +73.38% | +3.89% | - | 64.69 Mrd. | ||
| +0.84% | +7.95% | -6.73% | -0.25% | +9.91% | +10.86% | +79.09% | +220.50% | +5’650.36% | 54.78 Mrd. | ||
| +0.35% | +3.39% | +8.52% | +13.34% | +17.89% | +9.57% | +100.70% | -15.96% | +259.82% | 53.49 Mrd. | ||
| +0.19% | +5.68% | +3.70% | +31.78% | +24.66% | +29.23% | +52.36% | +9.72% | +284.28% | 45.98 Mrd. | ||
| -1.21% | +0.81% | +1.68% | +14.50% | +22.83% | +18.30% | +125.00% | -2.73% | +1’033.88% | 42.94 Mrd. | ||
| -1.57% | +2.92% | -7.08% | -0.32% | +135.35% | +223.26% | +841.54% | +590.97% | - | 40.08 Mrd. | ||
| +0.05% | +0.21% | +9.58% | +9.46% | +12.77% | +18.06% | +48.50% | +9.22% | +166.77% | 33.52 Mrd. | ||
| +0.22% | -8.29% | -14.04% | +18.73% | +45.99% | +23.12% | +3.15% | -61.75% | - | 23.97 Mrd. | ||
| +13.26% | +16.84% | +29.02% | +55.66% | +46.52% | +58.82% | +46.45% | +0.85% | +169.02% | 23.67 Mrd. | ||
| +0.11% | -1.06% | -10.92% | -3.11% | -7.29% | -16.78% | -8.67% | -69.81% | - | 22.13 Mrd. | ||
| +0.42% | -1.53% | -20.26% | -10.41% | -46.09% | -42.79% | +267.24% | +249.33% | +570.21% | 20.39 Mrd. | ||
| -0.38% | +8.20% | +8.85% | +13.76% | +19.37% | +12.40% | +162.02% | +214.74% | +2’159.69% | 18.72 Mrd. | ||
| +2.20% | +16.73% | +18.88% | +56.13% | +75.56% | +79.33% | +100.03% | -18.53% | +349.03% | 16.49 Mrd. | ||
| +1.72% | +9.12% | +9.43% | +28.72% | +38.04% | +39.88% | +88.33% | -16.01% | +110.56% | 16.47 Mrd. | ||
| +1.23% | +3.75% | +11.41% | +16.52% | +48.37% | +62.62% | +209.81% | +200.23% | +481.66% | 15.99 Mrd. | ||
| +0.56% | +6.83% | +6.78% | -3.07% | - | - | - | - | - | 15.98 Mrd. | ||
| -1.28% | -6.83% | +0.43% | +2.20% | +173.78% | +155.82% | +346.24% | +1’376.69% | +747.45% | 14.75 Mrd. | ||
| -0.42% | +9.22% | +4.60% | +8.81% | +0.78% | +0.89% | -23.66% | -35.59% | +125.55% | 14.29 Mrd. | ||
| +4.30% | +2.61% | +5.49% | -6.48% | +22.44% | +11.78% | +548.92% | - | - | 14.03 Mrd. | ||
| Durchschnitt | +1.09% | +3.25% | +1.12% | +11.55% | +37.73% | +39.21% | +167.03% | +144.87% | +931.41% | 27.62 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +0.95% | +3.21% | +0.77% | +13.62% | +37.89% | +40.48% | +160.30% | +123.11% | +1’266.89% |
- Börse
- Aktien
- A4211W Aktie
- Sektor Satellos Bioscience Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















